We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

4 Firms Lead French Biotech Genfit's Estimated $132M IPO

Law360 (March 14, 2019, 5:17 PM EDT) -- French biotechnology company Genfit SA on Thursday launched plans for an estimated $132 million United States initial public offering, guided by four law firms, that will help fund therapies treating potentially deadly...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.